Related Experiment Videos
[Castleman's disease: description and comments on 3 cases]
R Arranz1, C Montesinos, M López Botet
1Servicios de Hematología, Hospital de la Princesa, Madrid.
Insights
Castleman disease presents heterogeneously. Localized forms (HV) are surgically treated, while symptomatic multicentric forms (PC) respond well to chemotherapy or steroids.
Area of Science:
- Hematology
- Oncology
- Pathology
Background:
- Castleman disease is a rare lymphoproliferative disorder with diverse clinical and histological presentations.
- Understanding its heterogeneity is crucial for accurate diagnosis and effective treatment strategies.
Observation:
- Presents three distinct cases of Castleman disease: one localized hyaline-vascular (HV) form and two multicentric plasmocellular (PC) forms.
- The HV case was asymptomatic and treated with surgical resection.
- The PC cases exhibited varied clinical symptoms, with one responding to polychemotherapy and the other to steroids.
Findings:
- Demonstrates the clinical heterogeneity of Castleman disease, ranging from localized to multicentric forms.
- Highlights successful therapeutic outcomes with different modalities based on disease subtype and presentation.
- Underscores the challenges in defining Castleman disease as a singular entity due to its varied nature.
Implications:
- Emphasizes the need for individualized treatment approaches in Castleman disease management.
- Suggests further research into the pathogenesis and classification of Castleman disease subtypes.
- Informs clinical practice regarding the diagnosis and management of this complex disorder.
Abstract:
Three representative cases of the clinical heterogeneity of Castleman's disease are presented: one localized form with hialine vascular histology (HV) and 2 multicentric forms corresponding to the plasmocellular variety (PC). The asymptomatic patient with HV was treated with surgical resection of one tumor. The 2 patients with the symptomatic PC variant were characterized by the different clinical presentation receiving polychemotherapy and steroids, respectively with good response. The literature is reviewed and the pathogenetic, clinical and therapeutic aspects of the disease, which remains difficult to define as a sole entity, are discussed.